TransMedics (TMDX) Share-based Compensation Growth (3y) (2021 - 2026)
TransMedics (TMDX) Share-based Compensation Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 8.37% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | -28.31% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 13.19% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 4.11% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | -0.59% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 17.13% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 36.49% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 3.40% |
| 10 | TransMedics | 3.22 Bn | 2.74 Bn | 113.20 Mn | 122.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 122.21% |
| Mar 31, 2026 | 36.41% |
| Dec 31, 2025 | -39.66% |
| Sep 30, 2025 | 192.26% |
| Jun 30, 2025 | 220.01% |
| Mar 31, 2025 | 57.11% |
| Sep 30, 2024 | 59.09% |
| Jun 30, 2024 | 61.69% |
| Mar 31, 2024 | 83.49% |
| Dec 31, 2023 | -167.04% |
| Sep 30, 2023 | 94.97% |
| Jun 30, 2023 | 98.80% |
| Mar 31, 2023 | 116.76% |
| Dec 31, 2022 | 119.71% |
| Sep 30, 2022 | 109.28% |
| Jun 30, 2022 | 119.17% |
| Mar 31, 2022 | 243.49% |
| Dec 31, 2021 | 236.71% |
| Sep 30, 2021 | 299.26% |
| Jun 30, 2021 | 276.05% |